Revolution Medicines Inc
RVMD
Market Cap$6.68B
Close$
$4.92
87.4% downside
Current Fair Value
87.4% downsideOvervalued by 87.4% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $6.68 Billion |
|---|---|
| Enterprise Value | $4.92 Billion |
| Dividend Yield | $0.0 (0.0%) |
| Earnings per Share | $-3.86 |
| Beta | 1.27 |
| Outstanding Shares | 170,493,148 |
| Avg 30 Day Volume | 1,426,743 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | -15.31 |
|---|---|
| PEG | -8.24 |
| Price to Sales | - |
| Price to Book Ratio | 3.92 |
| Enterprise Value to Revenue | 424.58 |
| Enterprise Value to EBIT | -10.09 |
| Enterprise Value to Net Income | -12 |
| Total Debt to Enterprise | 0.02 |
| Debt to Equity | 0.05 |
Revenue Sources
No data
ESG Score
No data
About Revolution Medicines Inc
CEO: Mark Goldsmith